Cosmetics supplier verification in China: checking the manufacturing chain
Editorial illustration
GURI Journal · Published 31 October 2026
A supplier can present attractive cosmetic samples without controlling every step needed to reproduce them. The company answering your emails may sell the product, another business may make the bulk formula, and a third may fill the containers. This arrangement can work. The difficulty begins when nobody clearly owns the gaps between those activities.
GURI approaches verification as a review of a particular manufacturing plan. The useful question is whether the proposed chain can deliver your formula, packaging and evidence consistently. A company registration check is one part of that work; it does not establish the suitability of a production process or approve a cosmetic for its destination market.
Identify the businesses behind the proposal
Match the contracting entity, invoice issuer and proposed payment recipient. Ask the supplier to explain differences before commercial commitments become difficult to change. Confirm that your contact is authorised to represent the business and identify who can approve technical changes.
Then establish the actual manufacturing address and activities. China's cosmetics production and operation rules provide for manufacturing licensing and traceability. Check the relevant company's details and production scope rather than relying on a licence image in a sales presentation.
This review concerns the manufacturing side of the supply chain. Product requirements in the destination country remain a separate question. A supplier's experience with one market does not establish that its standard formula, claims and documentation are suitable for another.
Ask where each operation happens
Map formula development, bulk manufacture, filling, packaging assembly and testing. Identify subcontracted operations and the business responsible for their output. You do not need a complicated diagram; a clear list of activities, sites and decision makers often exposes the important gaps.
For example, the filling factory may be capable of using your chosen bottle but may not control its material specification. Who approves a change in that bottle, and who assesses the consequences for the product? If the answer passes between three companies, resolve the responsibility before approving the final pack.
Match capability to the product you intend to buy. Experience with one cosmetic format is useful evidence, but it is not proof of competence with every formulation or filling process. Ask for relevant process information and explain the expected order size and packaging configuration.
Review how a batch can be traced
Ask the manufacturer to demonstrate how a finished batch connects to raw materials, production records, packaging and release information. An anonymised example can show the process without disclosing another customer's confidential project.
The purpose is to test whether records support decisions. Who authorises material use? How are unresolved results handled? Can the company identify the affected output after a packaging problem? A tidy document template is less useful than an explanation of how people use it when something goes wrong.
Discuss retained samples, complaint handling and access to relevant information within applicable requirements. If a customer reports a change in the product, the supplier should be able to connect the report to the relevant production history. Agree what your business will receive and what will be available to qualified investigators.
Separate audits from product evidence
A factory audit, a test report and a product compliance assessment answer different questions. Intertek's cosmetics supply-chain services distinguish supplier qualification, production-site reviews and product-related work. That distinction is useful when deciding what to commission.
Check the scope and date of any audit, the site visited and the status of significant findings. An audit summary should not be treated as a lifetime approval of the supplier. Likewise, a test report must be linked to an identifiable sample and relevant configuration; a similar product name is insufficient.
If access to evidence is restricted for confidentiality reasons, agree an appropriate route for qualified specialists. Protecting commercial information and providing the information needed for an assessment are compatible goals. A blanket refusal to supply relevant evidence is a different situation and should remain visible in the decision.
Agree how the product may change
Record the approved formula identifier and packaging specification. Establish which changes require notice and assessment before implementation. A replacement fragrance, raw material or contact packaging component should not be accepted merely because the supplier describes it as equivalent.
For an illustrative case, suppose the original pump becomes unavailable. The replacement may look similar but dispense differently. The purchasing issue is therefore broader than price: identify the changed part, assess the finished combination and update the approval record where necessary.
End the review with specific findings rather than a general label such as “fully reliable”. State what has been verified, what remains unresolved and which conditions must be met before production. Carry those conditions into the specification and commercial agreement. Verification is useful when it changes how the order is managed, not when it produces a reassuring file that nobody uses again.